Pharmaceutical Costs
This House Small Business Subcommittee heard testimony from three panels of doctors, pharmaceutical corporation administrators and public he… read more
This House Small Business Subcommittee heard testimony from three panels of doctors, pharmaceutical corporation administrators and public health experts on the prices of prescription drugs. The subcommittee specifically sought to hear testimony on proposals to control the costs of prescription drugs, particularly those developed with federal grants to the pharmaceutical companies. close
People in this video
- Reid Adler Director National Institutes of Health->Office of Technology
- Peter Arno Associate Professor Einstein (Albert) College of Medicine
- Bruce Chabner Director National Cancer Institute->Cancer Treatment
- Alan Garber Administrator Department of Veterans Affairs
- Michael Gluck Representative Office of Technology Assessment
- Karen Guth Denver, CO
- Zola Horovitz Bristol-Myers Squibb Company->Licensing
- James Love Economist Russell Zigler and Company
- Ellen Stovall Representative National Coalition for Cancer Surviv.
Hosting Organization
Related Video
-
International Drug Costs
The subcommittee heard testimony from representatives of pharmaceutical companies and consumer groups on the relative pr…
-
Health Care Reform Issues
The House Ways and Means subcommittee on Health held a hearing on Healthcare Reform ideas and the impact of rising healt…
-
Business and Medical Technology Transfer
The subcommittee heard testimony on the research program of the National Institutes of Health, and how the technology of…
-
Presidential Health Care Proposal
Following a speech in Nashua, New Hampshire, President Clinton responded to journalists questions while shaking hands wi…